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DNA encoding ricin A chain was derived from preproricin cDNA and ligated into the expression vector 
pDS5/3. Transcription is controlled from the coliphage promoter P ~25 fused with the lac operator of E.coli. 
When induced, E.coZi 71.18 cells transformed with the recombinant plasmid express ricin A chain which 
is soluble and has full biological activity. 
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1. INTRODUCTION 
Ricin, the toxic lectin from Ricinus communis 
seeds, consists of two distinct polypeptides (the A 
and B chains) joined by a single disulphide bond. 
The B chain is a galactose-binding lectin which 
allows ricin to bind to cells. The A chain then 
traverses the plasma membrane or, more likely, the 
membranes of an endocytic vesicle and kills the cell 
by catalytically inactivating the 60 S ribosomal 
subunits (review [ 11). 
Ricin A chain has been widely used for the con- 
struction of immunotoxins. These are cell-type 
specific cytotoxic agents formed by coupling the A 
chain chemically to a cell reactive antibody (review 
[2,3]). One problem in using the A chain derived 
from native ricin is that lengthy procedures are 
needed to exclude all traces of the contaminating B 
chain which is essential to prevent non-specific tox- 
icity [4]. A second problem is that ricin A chain is 
N-glycosylated and has to be deglycosylated to pre- 
vent the rapid clearance of immunotoxins in vivo 
by liver cells which have receptors for the mannose 
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and fucose residues present on the A chain [5,6]. 
An obvious solution to these problems is to use a 
recombinant ricin A chain expressed in bacteria. 
Both cDNA [7] and genomic [8] clones have been 
characterized from which the DNA encoding the A 
chain can be derived. Prokaryotic systems are the 
most appropriate for expression not only because 
they do not glycosylate proteins but because their 
70 S ribosomes are not inactivated by the A chain. 
In the present paper we describe the synthesis of 
the recombinant ricin A chain in E. coli. The A 
chain, which was readily purified from E. coli 
lysates by chromatofocusing, was a potent in- 
hibitor of protein synthesis by eukaryotic 
ribosomes. 
2. MATERIALS AND METHODS 
2.1. Materials 
Restriction endonucleases, T4 ligase, [35S]- 
methionine, [‘4C]leucine and biotinylated protein 
Ajstreptavidin-horseradish peroxidase were ob- 
tained from Amersham (Bucks, England). 
Isopropyl P-D-thiogalactopyranoside (IPTG), am- 
picillin, phenylmethylsulfonyl fluoride (PMSF) 
and lysozyme (grade 1) were obtained from Sigma 
(Dorset, England). Polybuffer exchanger PBE 94 
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and polybuffer 96 were from Pharmacia (Uppsala, 
Sweden). Vector pDS5/3 was kindly provided by 
Dr B. Dobberstein, EMBL (Heidelberg, FRG). 
2.2. General methods 
Plasmid DNAs were prepared by the alkaline 
lysis method [9] and purified by centrifugation in 
cesium chloride-ethidium bromide. Restriction en- 
zyme -digests and ligations were carried out as 
recommended by the suppliers. 
2.3. Construction of pRICA 
An 893 bp BarnHI fragment containing the en- 
tire A chain coding region was derived from the 
preproricin cDNA described [7]. This DNA had 
earlier been mutagenized to create an XhoI site at 
- 15 (i.e. 15 bp 5 ’ to the mature A chain se- 
quence). The fragment was further modified in 
M 13 mp8 by oligonucleotide-directed mutagenesis 
to create a stop codon immediately after the C- 
terminal codon of ricin A chain (fig. la) using stan- 
dard procedures [lo]. Synthetic oligonucleotides 
were synthesized using an Applied Biosystems 
380B DNA synthesizer and purified by HPLC. An 
XhoI-SalI fragment containing the modified A 
chain sequence was then isolated and ligated into 
SalI-digested pUC18. An 873 bp BarnHI fragment 
of pUC18, which contains the ricin A chain se- 
quence with an additional 26 bp at the 5’-end, was 
ligated into BarnHI-digested pDS5/3 [l l] to 
generate pRICA (fig. 1 b). 
2.4. Expression of A chain in E. coli 
For expression, recombinant plasmids were in- 
troduced into E. coli strain 71.18 by calcium 
chloride-mediated transformation. 500 ml cultures 
were grown at 30°C in the presence of ampicillin 
(50 pug/ml) and IPTG (2 mM) to an Asso of 0.8. In 
some cultures, proteins synthesized in E. coli were 
radiolabeled by adding [35S]methionine (1000 
Ci/mmol) to the medium (300,&i/100 ml 
medium). E. coli cells were harvested by cen- 
trifugation and resuspended in 2 ml of 0.15 M 
NaCl, 10 mM Na phosphate, pH 7.4, containing 
1 mM PMSF. Lysozyme was added to 2 mg/ml 
and, after standing for 10 min on ice, the cells were 
lysed on ice by sonication in three x 20 s bursts 
using an MSE ultrasonic disintegrator (amplitude 
24). Lysates were cleared by centrifugation at 
12000 x g for 30 min at 4°C. 
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2.5. Isolation of recombinant A chain 
Cell free lysate supernatants were dialyzed 
against 25 mM ethanolamine, pH 9.4, and passed 
over a chromatofocusing column of polybuffer ex- 
changer PBE 94 (1.6 x 30 cm) equilibrated in the 
same buffer. A pH gradient (pH 9.4-6.0) was 
developed by passing through the column 600 ml 
of polybuffer 96 (diluted 1: 10 in HzO). Fractions 
having a pH of 7.5 (close to the p1of ricin A chain 
[ 11) were analyzed by SDS-polyacrylamide gel elec- 
trophoresis [12] and Western blotting [13]. Blots 
were probed with rabbit antibodies raised against 
ricin A chain purified from R. communis seeds 
[14] and developed using the biotinylated protein 
A/streptavidin peroxidase system (according to the 
manufacturer’s instructions). Immunoprecipita- 
tion was performed as described [12]. 
The level of expression of the recombinant ricin 
A chain was estimated as 2-3 mg/l of culture 
when cells were grown at 30°C. When bacteria 
were grown at 37°C ricin A chain formed small ag- 
gregates which could still be recovered in the super- 
natant fraction after centrifuging cell lysates. The 
aggregates had greatly reduced biological activity. 
2.6. Activity of recombinant A chain in 
reticulocyte fysates 
The biological activity of the recombinant ricin 
A chain produced at 30°C was determined by its 
ability to inhibit [i4C]leucine incorporation into 
protein in a rabbit reticulocyte lysate [15]. Ranges 
of recombinant A chain or A chain concentrations 
(0.5-16 ng/ml) purified from native toxin were 
assayed for inhibition with respect o controls over 
a 5 min translation period at 28°C. Each concen- 
tration was assayed in triplicate. 
2.7. Inhibition of protein synthesis in cultured 
cells 
Protein synthesis was assayed by incubating 2 x 
lo4 Vetro cells in 0.1 ml Glasgow’s modification of 
Eagle’s medium (GMEM) containing 5% fetal calf 
serum supplemented with 0.1% glutamine in 96 
well plates at 37°C in 5% COZ. Toxin and control 
solutions were added in 25 ~1 volumes to cells 
washed in phosphate buffered saline (PBS) as 
described in the figure legend. After 20 h each well 
was pulsed for 2 h with 1 ,uCi [35S]methionine in
50~1 PBS at 37°C. After washing cells in PBS, 
proteins were precipitated with 0.5 M NaOH, the 
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precipitate collected and counted. All assays were 
performed in triplicate. 
3. RESULTS AND DISCUSSION 
In constructing the expression plasmid pRICA, 
we isolated a ricin A chain containing BamHI frag- 
ment from preproricin cDNA [7]. Oligonucleotide- 
directed mutagenesis was used to create a unique 
X/z01 site 5 ’ to the A chain coding sequence and a 
termination codon immediately after the A chain 
coding sequence (fig. la). This fragment encodes 
the last four residues of the preproricin N-terminal 
leader followed by the complete sequence of the 
mature A chain. After mutagenesis, a fragment 
spanning the region from the newly created XhoI 
site to the polylinker &zZI site was isolated and 
subcloned in pUC18. This step preserved the 
reading frame after the final fusion of a BamHI 
fragment into the expression site of the vector 
pDS5/3 [l 11. This vector contains the strong col- 
iphage T5 promoter PN25 fused to the E. coli luc 
operator, with a ribosome binding site (RBS) and 
initiation codon immediately upstream from a uni- 
que BarnHI expression site. Downstream are se- 
quences for efficient transcription termination. As 
shown in fig.lb, the expression plasmid pRICA, 
directs the synthesis of a fusion protein in which 
the recombinant A chain sequence (267 amino acid 
residues) is preceded by a 10 residue N-terminal ex- 
tension, of which one residue (Met) is derived from 
the vector, 5 residues are from the pUC18 
polylinker and 4 residues are from the A chain N- 
terminal leader. The calculated molecular mass of 
recombinant ricin A chain is approx. 30 kDa. 
E. coli 71.18 cells were transformed with vector 
alone or with a recombinant plasmid containing 
the ricin A chain DNA insert either in the correct 
orientation for expression or in the reverse orienta- 
tion. When transformants were grown in L broth 
supplemented with ampicillin, the inducer IPTG 
and [3’S]methionine to radiolabel cellular proteins, 
rabbit antibodies raised against ricin A chain 
precipitated a polypeptide of apparent molecular 
mass 30 kDa from supernatants of cells transform- 
ed with the expression vector pRICA (fig.2, lane 
2). This polypeptide was not detected in super- 
natants from cells transformed with vector 
(pDS513) alone (fig.2, lane 4) or with vector con- 
taining the insert in the reverse orientation (fig.2, 
a 
SIGNAL A LINKER B 
‘11 3’ 
/S Cl F 5 L L I\ 
GT GTC AAA ACT AAC GAA TA MUTAGENIC 
I OLIGO 
S 0 F STOP 
5’..... TCA CAG TTT TGA TTG CTT ATA . . 3’ 
b 
N-termlnua of fuslan protmln 
RBS ATG GGA TCC TCT AGA GTC GAG GAT AAC AAC ATA “C..... 
M G S S R V E D N N A chain 
Fig.1. Construction of the ricin A chain expression 
plasmid. (a) An 873 bp BumHI fragment which 
contained the 5 ’ XhoI site and the entire A chain coding 
sequence was modified in Ml3 mp8 by site-directed 
mutagenesis to create a stop codon using a synthetic 
19-mer oligonucleotide. (b) The modified BarnHI 
fragment (after a subcloning step not illustrated here) 
was ligated into the BumHI expression site of the E. coli 
expression plasmid pDS S/3. X/S refers to an XhoI and 
WI ligation. 
lane 3). Supernatants from transformants express- 
ing ricin A chain were passed over a 
chromatofocusing column. A sharp protein peak 
eluted around pH 7.5 the pZ of ricin chain (not 
shown). When fractions across the peak were 
assayed by SDS-polyacrylamide gel electrophoresis 
they were highly enriched for the 30 kDa polypep- 
75 
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Fig.2. Expression of ricin A chain in E. coli 
transformants were labeled with [35S]methionine, lysed 
and immunoprecipitates obtained using rabbit anti-ricin 
A chain serum. These were separated by SDS-PAGE and 
visualized by fluorography. Lanes: 1, molecular mass 
markers; 2, cells transformed with vector containing 
ricin A chain inserted in the correct orientation for 
expression; 3, cells transformed with vector containing 
the insert in the reverse orientation; 4, cells transformed 
with the vector alone. 
tide (fig.3a, lanes 2-5), which reacted strongly 
with antibodies raised against ricin A chain (fig.3b, 
lanes 2-5). The A chain isolated from native ricin 
(fig.3a,b, lane 1) was a mixture of two molecular 
forms, a 31 kDa polypeptide containing one, or a 
33 kDa polypeptide containing two oligosac- 
charide chains [16]. The recombinant A chain, 
despite having an extra 10 N-terminal amino acids, 
was smaller than either of the authentic A chain 
forms because it is not glycosylated. 
Ran A-chain (ngiml) 
The recombinant A chain had virtually the same 
ability as native A chain to inhibit protein synthesis 
Fig.4. Biological activity of the recombinant A chain. 
Recombinant A (+) and pure native A chain (0) were 
in rabbit reticulocyte lysates (fig.4). Both the tested for their ability to inhibit cell-free protein 
recombinant and the native A chain had ICse synthesis in the rabbit reticulocyte assay. 
Fig.3. Identification of recombinant ricin A chain. 
Fractions across the pH 7.5 peak from the 
chromatofocusing column were subjected to SDS-PAGE 
and silver stained (a, lanes 2-5) or blotted onto 
nitrocellulose and probed with anti-ricin A chain 
antibodies (b, lanes 2-5). In both cases lane 1 contained 
the purified ricin A chain. The second band of slightly 
lower mobility seen in lane 1 (b) is heavy A chain [4]. 
0 Native A-chain 
* Recomb. A-chain 
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Fig.5. Cytotoxicity of the recombinant A chain to Vero 
cells. Cells were plated out at 2 x 10’ cells/ml in 96 well 
plates and treated, as described in section 2, with native 
ricin (A), native B chain (o), recombinant A chain (0) 
and recombinant A chain preincubated at 4°C for 24 h 
with 10m9 M native B chain (A). Cells were incubated in 
GMEM for 20 h at 37°C. Each well was then pulsed with 
1 pCi [“Slmethionine for 2 h before determining the 
radioactivity incorporated into protein. The 
incorporation observed was expressed as percentages 
relative to untreated controls. 
values (the concentration required for 50% inhibi- 
tion of protein synthesis) of around 1 ng/ml. The 
extra 10 amino acid residues at the N-terminus of 
recombinant A chain (fig. lb) therefore did not af- 
fect its catalytic activity. Equivalent dilutions of E. 
coli extracts alone had no effect on protein syn- 
thesis. 
Recombinant A chain was translocationally 
competent in a whole cell assay after reassociation 
with purified ricin B chain. Fig.5 shows that prein- 
cubation of Vero cells with either pure B chain or 
the recombinant A chain over the concentration 
range indicated had no effect on the protein 
biosynthetic capacity when compared to untreated 
cells. Over the same concentration range intact 
ricin was inhibitory. When the recombinant A 
chain, at the concentration indicated, was prein- 
cubated overnight with 10e9 M B chain, holotoxin 
was reconstituted with a cytotoxic potency virtual- 
ly indistinguishable from that of native ricin 
(fig.5). 
In conclusion, the recombinant ricin A chain ex- 
pressed in E. coli at 30°C is soluble, has full 
biological activity, and can be readily isolated in a 
single step by chromatofocusing. Since the recom- 
binant A chain is completely free from the con- 
taminating ricin B chain and is not glycosylated, it 
potentially provides a superior preparation for the 
construction of ricin A chain immunotoxins. 
Houston and his co-workers [8] have recently 
prepared immunotoxins from a recombinant ricin 
A chain derived from genomic preproricin clones 
and found them to be as potently cytotoxic as 
native ricin A chain immunotoxins (Houston, 
L.L., personal communication). 
ACKNOWLEDGEMENT 
This work was supported by the Science and 
Engineering Research Council via grant 
GR/D/8 1770. 
REFERENCES 
[ll 
121 
131 
[41 
[51 
161 
171 
181 
191 
WI 
Olsnes, S. and Pihl, A. (1982) in: Molecular Action 
of Toxins and Viruses (Cohen, P. and Van 
Heyningen, S. eds) pp.51-105, Elsevier, New 
York. 
Thorpe, P.E. (1985) in: Monoclonal Antibodies 
‘84: Biological and Clinical Applications (Pinchera, 
A. et al. eds) pp.475-512, Editrice Kurtis s.r.l., 
Milan. 
Vitetta, E.S. and Uhr, J.W. (1985) Annu. Rev. 
Immunol. 3, 197-238. 
Fulton, R.J., Blakey, D.C., Knowles, P.P., Uhr, 
J.W., Thorpe, P.E. and Vitetta, E.S. (1986) J. 
Biol. Chem. 261, 5314-5319. 
Skilleter, D.N., Price, R.J. and Thorpe, P.E. 
(1985) Biochim. Biophys. Acta 842, 12-21. 
Blakey, D.C., Watson, G.J., Knowles, P.P. and 
Thorpe, P.E. (1987) Cancer Res. 47, in press. 
Lamb, F.I., Roberts, L.M. and Lord, J.M. (1985) 
Eur. J. Biochem. 148, 265-270. 
Halling, K.C., Halling, A.C., Murray, E.E., 
Ladin, B.F., Houston, L.L. and Weaver, R.F. 
(1985) Nucleic Acids Res. 13, 8019-8033. 
Birnboim, H.G. and Doly, J. (1979) Nucleic Acids 
Res. 7, 1513-1523. 
Zoller, M. J. and Smith, M. (1982) Nucleic Acids 
Res. 10, 6487-6500. 
77 
Volume 216, number 1 FEBS LETTERS May 1987 
[l l] Steuber, D., Ibrahimi, I., Cutler, D., Dobberstein, 
B. and Bujard, H. (1984) EMBO J. 3, 3143-3148. 
[12] Roberts, L.M. and Lord, J.M. (1981) Eur. J. Bio- 
them. 119, 31-41. 
[13] Burnette, W.N. (1981) Anal. Biochem. 112, 
195-203. 
[14] Saltvedt, E. (1976) Biochim. Biophys. Acta 451, 
536-548. 
[15] Thorpe, P.E., Brown, A.N.F., Ross, W.C.J., 
Cumber, A. J., Detre, S.I., Edwards, D.C., Davies, 
A.J.S. and Stirpe, F. (1981) Eur. J. Biochem. 116, 
447-454. 
[16] Foxwell, B.M. J., Donovan, T.A., Thorpe, P.E. 
and Wilson, G. (1985) Biochim. Biophys. Acta 840, 
193-203. 
78 
